免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

FDA 510(k)

CARTO™ 3 EP導航系統 V8.4

K 號:K252972 · 2026-02-20

決定日期2026-02-20
產品代碼DQK
諮詢委員會履歷
決定相當於

器材摘要

CARTO™ 3 EP Navigation System V8.4 is the device name listed in this FDA 510(k) record. The listed applicant is Biosense Webster, Inc.. It received FDA 510(k) clearance on 2026-02-20 under 510(k) number K252972. The device is classified under product code DQK. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the CARTO™ 3 EP Navigation System V8.4?

CARTO™ 3 EP Navigation System V8.4 is a medical device that received FDA 510(k) clearance on 2026-02-20. The listed applicant is Biosense Webster, Inc.. The 510(k) number is K252972.

When did CARTO™ 3 EP Navigation System V8.4 receive FDA 510(k) clearance?

CARTO™ 3 EP Navigation System V8.4 received FDA 510(k) clearance on 2026-02-20, under 510(k) number K252972.

Who is the listed applicant for CARTO™ 3 EP Navigation System V8.4?

The FDA 510(k) record lists Biosense Webster, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CARTO™ 3 EP Navigation System V8.4?

The FDA product code for CARTO™ 3 EP Navigation System V8.4 is DQK.

相關臨床試驗

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

其他以 Biosense Webster, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

查看所有 25 項裝置 →

相關器械(代碼:DQK)

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係,請查閱連結的官方來源。

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊,請始終參閱官方記錄。

↑